Linaprazan glurate

DB21534InvestigationalSmall molecule

Linaprazan glurate is a small molecule drug. The usage of the INN stem '-prazan' in the name indicates that Linaprazan glurate is a proton pump inhibitor, not dependent on acid... Linaprazan glurate is under investigation in clinical trial NCT07037875 (A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)).

Formula / weight: C₂₆H₃₂N₄O₅ · 480.565 g/mol (avg)

Resolves to

Compound

UNII3VG4D399DTCAS1228559-81-6ChEMBLCHEMBL5095187

Structure

InChIKeyGPHPBXRKAJSSIC-UHFFFAOYSA-NSMILESCC1=C(C)N2C=C(C=C(NCC3=C(C)C=CC=C3C)C2=N1)C(=O)NCCOC(=O)CCCC(O)=O

What you can answer from here — as of September 16, 2026

8Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Linaprazan glurate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account